GlassScriptPhysician profile
Kecha A Lynshue
NPI 1467558924
$974.21
in general payments reported to CMS, 2019-2025
17 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2022: $34.55 · 2023: $144 · 2024: $198 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $221.98 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $100.25 | 2019-2025 | Omnipod |
| Abbvie INC. | $95.32 | 2022-2025 | |
| Beta Bionics, INC. | $74.47 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Novo Nordisk INC | $73.50 | 2025 | Sogroya, Wegovy |
| Ascendis Pharma Endocrinology INC | $64.33 | 2023-2025 | Skytrofa |
| Dexcom, INC. | $60.75 | 2019-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $50.56 | 2025 | Tymlos |
| Medtronic Minimed, INC. | $37.91 | 2019 | |
| Medtronic, INC. | $36.64 | 2023-2025 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Neurocrine Biosciences, INC. | $35.73 | 2025 | |
| Corcept Therapeutics | $29.10 | 2024 | Korlym |
| Eton Pharmaceuticals, INC. | $24.57 | 2025 | Alkindi, Increlex, Khindivi |
| Roche Diabetes Care, INC. | $18.66 | 2019 | |
| Abbott Laboratories | $17.77 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kecha Lynshue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.